NL6607516A - - Google Patents

Info

Publication number
NL6607516A
NL6607516A NL6607516A NL6607516A NL6607516A NL 6607516 A NL6607516 A NL 6607516A NL 6607516 A NL6607516 A NL 6607516A NL 6607516 A NL6607516 A NL 6607516A NL 6607516 A NL6607516 A NL 6607516A
Authority
NL
Netherlands
Application number
NL6607516A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to NL6607516A priority Critical patent/NL6607516A/xx
Priority to FR82837A priority patent/FR5953M/fr
Priority to GB22620/67A priority patent/GB1131007A/en
Priority to SE06961/67A priority patent/SE354417B/xx
Priority to IL28009A priority patent/IL28009A/en
Priority to GR670133861A priority patent/GR33861B/el
Priority to ES340956A priority patent/ES340956A1/es
Priority to SU1158241A priority patent/SU510986A3/ru
Priority to DE1617576A priority patent/DE1617576C3/de
Priority to BE699091D priority patent/BE699091A/xx
Priority to US641483A priority patent/US3557280A/en
Priority to DK282167AA priority patent/DK117587B/da
Priority to YU1086/67A priority patent/YU31326B/xx
Priority to FR108345A priority patent/FR1529966A/fr
Priority to IT37118/67A priority patent/IT1140250B/it
Priority to NO00168375A priority patent/NO126298B/no
Priority to AT502267A priority patent/AT272522B/de
Priority to FI1517/67A priority patent/FI43622B/fi
Priority to CH766867A priority patent/CH490087A/de
Priority to LU53788A priority patent/LU53788A1/xx
Priority to JP42034292A priority patent/JPS5010373B1/ja
Priority to CS3970A priority patent/CS151454B2/cs
Publication of NL6607516A publication Critical patent/NL6607516A/xx
Priority to MY15/71A priority patent/MY7100015A/xx
Priority to US05/267,087 priority patent/US3957972A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NL6607516A 1966-05-31 1966-05-31 NL6607516A (cg-RX-API-DMAC7.html)

Priority Applications (24)

Application Number Priority Date Filing Date Title
NL6607516A NL6607516A (cg-RX-API-DMAC7.html) 1966-05-31 1966-05-31
FR82837A FR5953M (cg-RX-API-DMAC7.html) 1966-05-31 1966-11-08
GB22620/67A GB1131007A (en) 1966-05-31 1967-05-16 Improvements in or relating to aqueous solutions of oxytetracycline
SE06961/67A SE354417B (cg-RX-API-DMAC7.html) 1966-05-31 1967-05-18
IL28009A IL28009A (en) 1966-05-31 1967-05-18 Process for the preparation of stable solutions of oxytetracycline in water,suitable for parenteral and peroral administration
GR670133861A GR33861B (el) 1966-05-31 1967-05-22 Μεθοδος δια την παρασκευην σταθερων εν των υδατι διαλυματων οξυτερακυκλινης, καταλληλων δια την παρεντερικην και την δια του στοματος χορηγησιν.
ES340956A ES340956A1 (es) 1966-05-31 1967-05-24 Procedimiento para la preparacion de soluciones estables deoxitetraciclina en agua adecuadas para administracion paren-teral, peronal y local.
SU1158241A SU510986A3 (ru) 1966-05-31 1967-05-25 Способ получени раствора окситетрациклина
DE1617576A DE1617576C3 (de) 1966-05-31 1967-05-26 Verfahren zur Herstellung eines Injektionspräparates auf Basis einer wäßrigen Lösung eines Oxytetracyclin-Magnesium-Komplexes
BE699091D BE699091A (cg-RX-API-DMAC7.html) 1966-05-31 1967-05-26
US641483A US3557280A (en) 1966-05-31 1967-05-26 Stable solutions of oxytetracycline suitable for parenteral and peroral administration and process of preparation
DK282167AA DK117587B (da) 1966-05-31 1967-05-30 Fremgangsmåde til fremstilling af stabile vandige opløsninger af oxytetracyclin egnet til parenteral, peroral og topisk indgivelse.
YU1086/67A YU31326B (en) 1966-05-31 1967-05-30 Postupak za dobijanje stabilnog vodenog rastvora oksitetraciklina pogodnog za parenteralnu, peroralnu i lokalnu upotrebu
FR108345A FR1529966A (fr) 1966-05-31 1967-05-30 Procédé de préparation de solutions aqueuses stables d'oxytétracycline
IT37118/67A IT1140250B (it) 1966-05-31 1967-05-30 Procedimento per la preparazione di soluzioni stabili di ossitetraciclina in acqua, adatte per somministrazioni per via parenterale ed orale
NO00168375A NO126298B (cg-RX-API-DMAC7.html) 1966-05-31 1967-05-30
AT502267A AT272522B (de) 1966-05-31 1967-05-30 Verfahren zur Herstellung von stabilen, für die parenterale und perorale Verabreichung geeigneten wässerigen Lösungen von Oxytetracyclin
FI1517/67A FI43622B (cg-RX-API-DMAC7.html) 1966-05-31 1967-05-30
CH766867A CH490087A (de) 1966-05-31 1967-05-31 Verfahren zur Herstellung von stabilen, für die parenterale, perorale und lokale Verabreichung geeigneten wässrigen Oxytetracyclinlösungen
LU53788A LU53788A1 (cg-RX-API-DMAC7.html) 1966-05-31 1967-05-31
JP42034292A JPS5010373B1 (cg-RX-API-DMAC7.html) 1966-05-31 1967-05-31
CS3970A CS151454B2 (cg-RX-API-DMAC7.html) 1966-05-31 1967-05-31
MY15/71A MY7100015A (en) 1966-05-31 1971-12-30 Improvements in or relating to aqueous solutions of oxytetracycline
US05/267,087 US3957972A (en) 1966-05-31 1972-06-28 Stable solutions of oxytetracycline suitable for parenteral and peroral administration and process of preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL6607516A NL6607516A (cg-RX-API-DMAC7.html) 1966-05-31 1966-05-31

Publications (1)

Publication Number Publication Date
NL6607516A true NL6607516A (cg-RX-API-DMAC7.html) 1967-12-01

Family

ID=19796753

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6607516A NL6607516A (cg-RX-API-DMAC7.html) 1966-05-31 1966-05-31

Country Status (22)

Country Link
US (1) US3557280A (cg-RX-API-DMAC7.html)
JP (1) JPS5010373B1 (cg-RX-API-DMAC7.html)
AT (1) AT272522B (cg-RX-API-DMAC7.html)
BE (1) BE699091A (cg-RX-API-DMAC7.html)
CH (1) CH490087A (cg-RX-API-DMAC7.html)
CS (1) CS151454B2 (cg-RX-API-DMAC7.html)
DE (1) DE1617576C3 (cg-RX-API-DMAC7.html)
DK (1) DK117587B (cg-RX-API-DMAC7.html)
ES (1) ES340956A1 (cg-RX-API-DMAC7.html)
FI (1) FI43622B (cg-RX-API-DMAC7.html)
FR (1) FR5953M (cg-RX-API-DMAC7.html)
GB (1) GB1131007A (cg-RX-API-DMAC7.html)
GR (1) GR33861B (cg-RX-API-DMAC7.html)
IL (1) IL28009A (cg-RX-API-DMAC7.html)
IT (1) IT1140250B (cg-RX-API-DMAC7.html)
LU (1) LU53788A1 (cg-RX-API-DMAC7.html)
MY (1) MY7100015A (cg-RX-API-DMAC7.html)
NL (1) NL6607516A (cg-RX-API-DMAC7.html)
NO (1) NO126298B (cg-RX-API-DMAC7.html)
SE (1) SE354417B (cg-RX-API-DMAC7.html)
SU (1) SU510986A3 (cg-RX-API-DMAC7.html)
YU (1) YU31326B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2615140A1 (de) * 1975-04-11 1976-10-21 Nelson Res & Dev Vehiculumsystem

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5418330B2 (cg-RX-API-DMAC7.html) * 1973-03-16 1979-07-06
US3966905A (en) * 1973-05-29 1976-06-29 Barnes-Hind Pharmaceuticals, Inc. Stabilized catechol amine solutions
US3929989A (en) * 1974-06-14 1975-12-30 Wendt Lab Inc Stable suspension of calcium-magnesium oxytetracycline for intrauterine administration in treatment of bovine metritis
US4018889A (en) * 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
DE2602363C2 (de) * 1976-01-22 1984-04-12 Bayer Ag, 5090 Leverkusen Wäßrige, injizierbare Niclofolan- Formulierungen
GB1592053A (en) * 1976-12-16 1981-07-01 Norbrook Lab Ltd Oxytetracycline compositions
US4213963A (en) * 1978-12-14 1980-07-22 Janssen Pharmaceutica N.V. Fluspirilene-containing compositions
US4259331A (en) * 1979-04-16 1981-03-31 Pfizer Inc. Oxytetracycline compositions
US4386083A (en) * 1980-04-10 1983-05-31 Walter Hacke Injectable oxytetracycline compositions
US4399127A (en) * 1980-04-10 1983-08-16 Diamond Shamrock Corporation Injectable oxytetracycline compositions
IE74244B1 (en) * 1985-10-01 1997-07-16 Bimeda Res Dev Ltd A process for preparing an antibiotic composition
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US6756365B2 (en) * 1991-11-06 2004-06-29 Trustees Of Tufts College Reducing tetracycline resistance in living cells
EP0626171A1 (de) * 1993-05-26 1994-11-30 Winfried Dörnhöfer Injektionslösung für die intravenöse oder intramuskuläre Verabreichung an Tiere
US6383515B2 (en) 1999-05-28 2002-05-07 Sawyer Maryjean Solvent system for enhancing solubility
US6849615B2 (en) 1999-09-14 2005-02-01 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
US6500812B2 (en) 1999-09-14 2002-12-31 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
US8106225B2 (en) * 1999-09-14 2012-01-31 Trustees Of Tufts College Methods of preparing substituted tetracyclines with transition metal-based chemistries
CZ301835B6 (cs) 1999-09-14 2010-07-07 Trustees Of Tufts College Zpusob prípravy 7-, 9- nebo 13- substituované tetracyklinové slouceniny, reaktivní tetracyklinový chemický komplex a tetracyklinová sloucenina substituovaná v poloze 7 nebo 9
CA2397863A1 (en) * 2000-01-24 2001-07-26 Trustees Of Tufts College Tetracycline compounds for treatment of cryptosporidium parvum related disorders
KR20030007489A (ko) * 2000-03-31 2003-01-23 트러스티즈 오브 터프츠 칼리지 7- 및 9-카르바메이트, 우레아, 티오우레아,티오카르바메이트 및 헤테로아릴-아미노 치환된테트라사이클린 화합물
EP2308863A1 (en) * 2000-05-15 2011-04-13 Paratek Pharmaceuticals, Inc. 7-substituted fused ring tetracycline compounds
AU2001268475A1 (en) * 2000-06-16 2002-01-02 Trustees Of Tufts College 7-phenyl-substituted tetracycline compounds
US20040224927A1 (en) * 2000-06-16 2004-11-11 Trustees Of Tufts College 7-N-substituted phenyl tetracycline compounds
US20020132798A1 (en) * 2000-06-16 2002-09-19 Nelson Mark L. 7-phenyl-substituted tetracycline compounds
CN1690047B (zh) 2000-07-07 2010-10-06 塔夫茨大学信托人 9-取代的二甲胺四环素化合物
US7094806B2 (en) * 2000-07-07 2006-08-22 Trustees Of Tufts College 7, 8 and 9-substituted tetracycline compounds
CN102336679A (zh) 2000-07-07 2012-02-01 塔夫茨大学信托人 7-取代的四环素化合物
JP4963771B2 (ja) 2000-07-07 2012-06-27 トラスティーズ・オブ・タフツ・カレッジ ７、８および９−置換テトラサイクリン化合物
AU2001271616A1 (en) 2000-07-07 2002-01-21 Paratek Pharmaceuticals, Inc 13-substituted methacycline compounds
US20050143353A1 (en) * 2000-07-07 2005-06-30 Paratek Pharmaceuticals, Inc. 13-Substituted methacycline compounds
EA201000388A1 (ru) 2001-03-13 2010-10-29 Пэрэтек Фамэсьютикэлс, Инк. Замещенные соединения тетрациклина (варианты), фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния субъекта
WO2002072506A2 (en) * 2001-03-13 2002-09-19 Paratek Pharmaceuticals, Inc. 7-pyrollyl tetracycline compounds and methods of use thereof
US6841546B2 (en) 2001-03-14 2005-01-11 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds as antifungal agents
EP1381372A2 (en) 2001-03-14 2004-01-21 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds as synergistic antifungal agents
EP2186793A1 (en) 2001-04-24 2010-05-19 Paratek Pharmaceuticals, Inc. Substituted Tetracycline Compounds
US8088820B2 (en) * 2001-04-24 2012-01-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
EP2311799A1 (en) * 2002-01-08 2011-04-20 Paratek Pharmaceuticals, Inc. 4-dedimethylamino tetracycline compounds
EA201000491A1 (ru) 2002-03-08 2010-08-30 Паратек Фармасьютикалс, Инк. Аминометилзамещенные тетрациклиновые соединения
AU2003218243B2 (en) 2002-03-21 2010-04-01 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
EA012136B1 (ru) 2002-07-12 2009-08-28 Пэрэтек Фамэсьютикэлс, Инк. Замещенные соединения тетрациклина, фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния у субъекта
CA2502464A1 (en) 2002-10-24 2004-05-06 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
AU2003261633A1 (en) * 2003-02-12 2004-09-06 R And P Korea Co., Ltd. Solvent system of hardly soluble drug with improved elution rate
US20060287283A1 (en) * 2003-07-09 2006-12-21 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
JP4738333B2 (ja) 2003-07-09 2011-08-03 パラテック ファーマシューティカルズ インコーポレイテッド ９−アミノメチルテトラサイクリン化合物のプロドラッグ
KR101228706B1 (ko) 2003-07-09 2013-02-01 파라테크 파마슈티컬스, 인크. 치환된 테트라시클린 화합물
US7786099B2 (en) * 2004-01-15 2010-08-31 Paratek Pharmaceuticals, Inc. Aromatic a-ring derivatives of tetracycline compounds
TWI261038B (en) * 2004-08-11 2006-09-01 Bo-Cheng Chen Bicycle gear-shifting handgrip
EP2284152A3 (en) 2004-10-25 2011-10-05 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
EP2301912A3 (en) 2004-10-25 2012-07-11 Paratek Pharmaceuticals, Inc. 4-aminotetracyclines and methods of use thereof
EP1848685A1 (en) 2005-02-04 2007-10-31 Paratek Pharmaceuticals, Inc. 11a, 12-derivatives of tetracycline compounds
DE102005012595A1 (de) * 2005-03-18 2006-09-21 Lanxess Deutschland Gmbh Herstellung von Tri(chlorpropyl)phosphat
WO2007014154A2 (en) * 2005-07-21 2007-02-01 Paratek Pharmaceuticals, Inc. 10-substituted tetracyclines and methods of use thereof
WO2007035448A2 (en) * 2005-09-19 2007-03-29 Albemarle Corporation Highly concentrated pourable aqueous solutions of potassium ibuprofen their preparation and their uses
AU2007208214B2 (en) 2006-01-24 2013-02-14 Paratek Pharmaceuticals, Inc. Methods of increasing oral bioavailability of tetracyclines
CN101489987A (zh) * 2006-04-17 2009-07-22 特瓦制药工业有限公司 四环素衍生物的分离
DE202007019460U1 (de) * 2006-04-24 2012-10-24 Teva Pharmaceutical Industries Ltd. Kristalline Tigecyclin-Formen
US8198470B2 (en) * 2006-04-24 2012-06-12 Teva Pharmaceutical Industries Ltd. Crystalline form II of tigecycline and processes for preparation thereof
AU2007249695A1 (en) * 2006-05-15 2007-11-22 Paratek Pharmaceuticals, Inc. Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
WO2008045507A2 (en) 2006-10-11 2008-04-17 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of bacillus anthracis infections
ES2463457T3 (es) 2006-12-21 2014-05-28 Paratek Pharmaceuticals, Inc. Derivados de la tetraciclina para el tratamiento de infecciones bacterianas, virales y parasitarias
ES2701725T3 (es) 2006-12-21 2019-02-25 Paratek Pharm Innc Compuestos de tetraciclina sustituida para el tratamiento de trastornos inflamatorios de la piel
EP2144614A1 (en) * 2007-04-12 2010-01-20 Paratek Pharmaceuticals, Inc. Methods for treating spinal muscular atrophy using tetracycline compounds
JP2010525069A (ja) 2007-04-27 2010-07-22 パラテック ファーマシューティカルズ インコーポレイテッド アミノアルキルテトラサイクリン化合物の合成方法および精製方法
EP2176216B1 (en) 2007-07-06 2012-04-25 Paratek Pharmaceuticals, Inc. Methods for synthesizing 9-substituted minocycline
US20090253660A1 (en) 2008-03-05 2009-10-08 Paratek Pharmaceuticals, Inc. Minocycline Compounds and Methods of Use Thereof
PT2271348T (pt) 2008-03-28 2018-04-16 Paratek Pharm Innc Formulação de comprimido oral de composto de tetraciclina
US20100022483A1 (en) * 2008-04-14 2010-01-28 Paratek Pharmaceuticals, Inc. Substituted Tetracycline Compounds
TW202436282A (zh) * 2008-05-19 2024-09-16 美商Ｐｒｔｋ Ｓｐｖ２公司 四環素化合物之甲苯磺酸鹽及同素異形體
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US9629806B2 (en) * 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
EP2341771A4 (en) * 2008-09-19 2012-08-15 Paratek Pharm Innc TETRACYCLINE COMPOUNDS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS AND RELATED THERAPEUTIC METHODS
JP2012523438A (ja) 2009-04-10 2012-10-04 タフツ メディカル センター インコーポレイテッド メタロプロテイナーゼ−１（ｍｍｐ−１）によるｐａｒ−１活性化
US9255068B2 (en) 2011-05-12 2016-02-09 Warner Chilcott Company, Llc Crystalline salts of (4S,4AS,5AR,12AS)-4-dimethylamino-3,10,12,12A-tetrahydroxy-7-[methoxy(methyl)amino)-methyl] acid amide and methods of using the same
MX2019005070A (es) 2016-11-01 2019-09-23 Paratek Pharm Innc Compuestos de 9-aminometil minociclina y su uso en el tratamiento de neumonía bacteriana adquirida en la comunidad (cabp).
EP3654988B1 (en) 2017-07-21 2023-09-06 Almirall, LLC Sarecycline for the treatment of non-inflammatory acne lesions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2615140A1 (de) * 1975-04-11 1976-10-21 Nelson Res & Dev Vehiculumsystem

Also Published As

Publication number Publication date
GR33861B (el) 1968-02-09
YU31326B (en) 1973-04-30
AT272522B (de) 1969-07-10
SU510986A3 (ru) 1976-04-15
CS151454B2 (cg-RX-API-DMAC7.html) 1973-10-19
MY7100015A (en) 1971-12-31
BE699091A (cg-RX-API-DMAC7.html) 1967-11-27
GB1131007A (en) 1968-10-16
DK117587B (da) 1970-05-11
ES340956A1 (es) 1968-06-16
JPS5010373B1 (cg-RX-API-DMAC7.html) 1975-04-21
IT1140250B (it) 1986-09-24
FI43622B (cg-RX-API-DMAC7.html) 1971-02-01
FR5953M (cg-RX-API-DMAC7.html) 1968-04-16
LU53788A1 (cg-RX-API-DMAC7.html) 1967-07-31
CH490087A (de) 1970-05-15
DE1617576C3 (de) 1980-12-11
SE354417B (cg-RX-API-DMAC7.html) 1973-03-12
DE1617576A1 (de) 1972-04-27
IL28009A (en) 1970-08-19
NO126298B (cg-RX-API-DMAC7.html) 1973-01-22
US3557280A (en) 1971-01-19
DE1617576B2 (de) 1980-04-10

Similar Documents

Publication Publication Date Title
AU5917865A (cg-RX-API-DMAC7.html)
AU424443B2 (cg-RX-API-DMAC7.html)
AU428063B2 (cg-RX-API-DMAC7.html)
AU414526B2 (cg-RX-API-DMAC7.html)
AU433222B2 (cg-RX-API-DMAC7.html)
AU421822B2 (cg-RX-API-DMAC7.html)
AU417216B2 (cg-RX-API-DMAC7.html)
AU415165B1 (cg-RX-API-DMAC7.html)
AU6703465A (cg-RX-API-DMAC7.html)
AU612166A (cg-RX-API-DMAC7.html)
AU1111066A (cg-RX-API-DMAC7.html)
AU5895065A (cg-RX-API-DMAC7.html)
AU218666A (cg-RX-API-DMAC7.html)
AU1144366A (cg-RX-API-DMAC7.html)
BE284991A (cg-RX-API-DMAC7.html)
BE597652A (cg-RX-API-DMAC7.html)
AU433620A (cg-RX-API-DMAC7.html)
AU2390066A (cg-RX-API-DMAC7.html)
AU415780B2 (cg-RX-API-DMAC7.html)
AU407778B2 (cg-RX-API-DMAC7.html)
BE674713A (cg-RX-API-DMAC7.html)
AU411645B2 (cg-RX-API-DMAC7.html)
AU6852465A (cg-RX-API-DMAC7.html)
AU855865A (cg-RX-API-DMAC7.html)
AU92366A (cg-RX-API-DMAC7.html)